Novel synthetic fusion promoter for improved GS-CHO expression of biotherapeutics

Historically, advancements in CHO-based recombinant protein production have been driven predominantly by process development, and whilst these efforts have delivered significant gains, they have also highlighted a need to optimize additional process inputs to accelerate platform development.